NAYA Biosciences Investor Relations Material
Latest events
Status Update
NAYA Biosciences
Q1 2025
21 May, 2025
Q4 2024
30 Apr, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NAYA Biosciences Inc
Access all reports
INVO Bioscience Inc develops and markets medical technologies for the treatment of infertility. The company offers devices and solutions designed to enable in vivo fertilization as an alternative to traditional in vitro fertilization procedures. INVO Bioscience operates within the healthcare and medical technology sectors. The company is headquartered in Sarasota, Florida, and its shares are listed on the NASDAQ.
Key slides for NAYA Biosciences Inc
Investor Presentation
NAYA Biosciences Inc
Investor Presentation
NAYA Biosciences Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
NAYA
Country
🇺🇸 United States